Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of ASBP will rise by +10.42% over the next 2 Weeks and hit $10.00 by Friday, September 25, 2026. In that time frame, ASBP's share price is expected to range between $9.58 and $10.46.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Sep 25, 2026 | 9.58 | 10.00 | 10.46 |
| Sep 24, 2026 | 9.31 | 9.74 | 10.17 |
| Sep 23, 2026 | 9.09 | 9.54 | 9.95 |
| Sep 22, 2026 | 9.33 | 9.76 | 10.19 |
| Sep 21, 2026 | 9.34 | 9.77 | 10.18 |
| Sep 18, 2026 | 9.19 | 9.61 | 10.02 |
| Sep 17, 2026 | 8.94 | 9.35 | 9.79 |
| Sep 16, 2026 | 8.70 | 9.15 | 9.57 |
| Sep 15, 2026 | 8.94 | 9.37 | 9.79 |
| Sep 14, 2026 | 8.94 | 9.38 | 9.83 |
ASBP shares fell -0.66% in Friday, September 11, 2026's trading session, dropping from a previous close of $9.12 to move at $9.06. The stock demonstrated notable intraday movement (see ASBP's key stats for a full breakdown), fluctuating between $9.06 and $9.38, a +3.51% trading range. While recent weeks have seen some volatility, ASBP has managed to secure a +6.46% gain over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 26.83K shares changing hands, 8.35K fewer than the previous session. This amounted to $243.12K in total market activity.
Will ASBP Continue Its Upward Trend?
According to analyst ratings and projections for ASBP, Aspire Biopharma Holdings, Inc. shares are anticipated to increase by +13.41%, potentially reaching $10.46 per share by September 25, 2026. Short-term technical indicators currently suggest a neutral sentiment for ASBP. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 14 positive trading days within the past 30 sessions. Based on the ASBP stock forecast, now is a good time to buy ASBP stock because its current trading price is -9.43% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on ASBP covering social and institutional perspectives.
ASBP Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into ASBP's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 58.66% to 62.99%) suggest the stock is showing bullish momentum with some volatility. The 50-day RSI, at 40.53%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 36.38%, signals a bearish bias in the long-term trend. Insights into ASBP's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Aspire Biopharma Short-Term Forecasts
ASBP Forecast For Next 5 Days
Our algorithm anticipates Aspire Biopharma (ASBP) stock could hit $9.61 by Sep 18, 2026. This represents a +6.03% fall from today's price, following a -47.11% change over the past five days.
ASBP Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Aspire Biopharma Holdings, Inc. (ASBP) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $9.88, which would mean a +9.05% increase from the current price of $9.06. Projections for this period range from a high of $11.16 to a low of $8.59.
ASBP Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Aspire Biopharma's price over the next three months point to a drop. ASBP stock is expected to peak at $282.96 on Dec 01, 2026 before potentially dipping to $0.00 on Dec 11, 2026. On average, ASBP is likely to trade around $0.00 in the coming 90 days.
Aspire Biopharma Stock Forecast 2025
Based on our predictive models, Aspire Biopharma (ASBP) is expected to trade between $0.00 and $282.96 throughout 2026. This would result in an average price of $0.00, potentially offering investors a -100.00% return from current levels.
Aspire Biopharma Holdings, Inc. Monthly Forecast 2026–2027
September 2026
According to our latest forecast models, Aspire Biopharma Holdings, Inc. (ASBP) is positioned to show a strong performance in September 2026. The price is predicted to move between $0.00 and $269.47, settling at an average of $0.00. This could translate to a -100.00% loss.
October 2026
Based on current market signals, Aspire Biopharma Holdings, Inc. is projected to trend october 2026. We forecast a trading range from $0.00 to $271.55, with a likely average price of $0.00. Investors could expect a potential return of -100.00%.
November 2026
Our predictive algorithms indicate Aspire Biopharma Holdings, Inc. stock may see a shift in November 2026. The expected range spans $0.00–$260.89, with an average target of $0.00. This represents a cautious outlook and a possible loss of -100.00%.
December 2026
Analyzing established trends, Aspire Biopharma Holdings, Inc. looks set to move in December 2026. Projections place the stock between $0.00 and $282.96, averaging around $0.00. This suggests a -100.00% loss from current levels.
January 2027
Market indicators suggest Aspire Biopharma Holdings, Inc. could experience notable changes during January 2027. Prices could fluctuate within $0.00 to $295.04, with a midpoint forecast of $0.00. The stock might deliver a -100.00% loss.
February 2027
Forecasting for February 2027, models estimate that Aspire Biopharma Holdings, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $292.46, averaging $0.00. This signals a cautious trajectory with potential returns around -100.00%.
March 2027
According to our latest forecast models, Aspire Biopharma Holdings, Inc. (ASBP) is positioned to show a strong performance in March 2027. The price is predicted to move between $0.00 and $273.67, settling at an average of $0.00. This could translate to a -100.00% loss.
April 2027
Based on current market signals, Aspire Biopharma Holdings, Inc. is projected to trend april 2027. We forecast a trading range from $0.00 to $282.11, with a likely average price of $0.00. Investors could expect a potential return of -100.00%.
May 2027
Our predictive algorithms indicate Aspire Biopharma Holdings, Inc. stock may see a shift in May 2027. The expected range spans $0.00–$273.41, with an average target of $0.00. This represents a cautious outlook and a possible loss of -100.00%.
June 2027
Analyzing established trends, Aspire Biopharma Holdings, Inc. looks set to move in June 2027. Projections place the stock between $0.00 and $266.57, averaging around $0.00. This suggests a -100.00% loss from current levels.
July 2027
Market indicators suggest Aspire Biopharma Holdings, Inc. could experience notable changes during July 2027. Prices could fluctuate within $0.00 to $288.63, with a midpoint forecast of $0.00. The stock might deliver a -100.00% loss.
August 2027
Forecasting for August 2027, models estimate that Aspire Biopharma Holdings, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $261.75, averaging $0.00. This signals a cautious trajectory with potential returns around -100.00%.
September 2027
According to our latest forecast models, Aspire Biopharma Holdings, Inc. (ASBP) is positioned to show a strong performance in September 2027. The price is predicted to move between $0.00 and $270.10, settling at an average of $0.00. This could translate to a -100.00% loss.
ASBP's history of dividends and stock splits also plays a role in long-term investor confidence.